Filing Details
- Accession Number:
- 0001178913-22-001181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-21 06:04:46
- Reporting Period:
- 2022-03-18
- Accepted Time:
- 2022-03-21 06:04:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534248 | Chemomab Therapeutics Ltd. | CMMB | Pharmaceutical Preparations (2834) | 813676773 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850990 | Michael Joel Maryles | 5 Atzmon St. Hashmonaim L3 7312700 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Acquisiton | 2022-03-18 | 500 | $4.32 | 500 | No | 4 | P | Direct | |
American Depositary Shares | Acquisiton | 2022-03-18 | 500 | $4.36 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2022-03-07 | 6,820 | $0.00 | 6,820 | $3.53 |
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2021-04-19 | 11,884 | $0.00 | 11,884 | $27.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,820 | 2032-03-07 | No | 4 | A | Direct | |
11,884 | 2031-04-19 | No | 4 | A | Direct |
Footnotes
- Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- These options vest and become exercisable in their entirety on March 16, 2023.
- These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.